INTRODUCTION:

Chromatography is a powerful analytical method that is widely used for the separation, identification and determination of the chemical components in complex mixtures. It was first demonstrated by the Russian botanist Milkhail Tswett in 1906.

Chromatographic process can be defined as separation technique involving mass-transfer between stationary phase and mobile phase. In these chromatography techniques, HPLC is one of the chromatographic techniques, which is mostly used analytical technique.

In This method stationary phase can be a liquid or a solid phase. HPLC utilizes a liquid mobile phase to separate the components of a mixture. High-performance liquid chromatography (HPLC) is the term used to describe liquid chromatography in which the liquid mobile phase is mechanically pumped through a column that contains the stationary phase. An HPLC instrument, therefore, consists of an injector, a pump, a column, and a detector.

HISTORY^3,4

Prior to HPLC, researchers used conventional liquid chromatographic techniques. Because the flow rate of solvents depends on gravity, liquid chromatographic techniques are inefficient. Separations take many hours, and maybe even days, to complete. Despite the fact that liquid chromatography (LC) at the time was more efficient, it was assumed that gas stage partition and research of extremely polar high atomic weight biopolymers were both impractical. GC was ineffective for some organic chemists because the solutes were thermally unstable. As a result, it was predicted that alternative methods would soon lead to the advancement of HPLC. International Journal of Research Publication and Reviews, Vol 3, no 7, pp 3014-3028, July 2022 3015 Following Martin and Synge’s pioneering work from 1941, it was predicted in the 1960s by Cal Giddings, Josef Huber, and others that LC could be operated in the high-efficiency mode by generously lowering the pressing molecule measurement below the standard LC (and GC) level of 150 m and using pressure. To increase the adaptable stage speed. All of these expectations were subjected to extensive experimentation and refinement. During the 1960s and into the 1970s. Early research was conducted to improve LC particles, and the invention For HPLC technique of Zipax, an externally permeable chemical. Numerous improvements in machinery and instrumentation were made throughout the 1970s. Injectors and pumps were first used by experts to construct a straightforward HPLC system. The fact that gas amplifier pumps operated at a constant pressure made them ideal. It did not need check valves or release free seals to maintain a constant flow and excellent quantitation. Although improvements in apparatus had a significant role, the history of HPLC is mostly the narrative of the evolution of molecular technology. There has been a consistent trend toward smaller molecules since the introduction of permeable layer particles to increase effectiveness. But when molecule sizes shrank, other problems emerged. The drawback from the unneeded pressure drop is anticipated to be the difficulty of setting up a uniform pressing of extremely fine materials as well as the difficulty of driving versatile liquid through the segment. To handle the pressure, another cycle of instrument advancement should typically take place every time the molecule size is completely reduced.

Historical Perspective:

· 1903 Tswett – plant pigments separated on chalk columns

· 1931 Lederer and Kuhn – LC of carotenoids

· 1938 TLC and ion exchange

· 1950 reverse phase LC

· 1954 Martin and Synge (Nobel Prize)

· 1959 Gel permeation

· 1965 instrumental LC (Waters) In order to distinguish the modern high performance technology from the traditional low-pressure column chromatography, which was invented in the 1930s, the term High Performance Liquid Chromatography (HPLC) was first used.

Principle⁵

PRINCIPLE OF HPLC: Ø HPLC principle is that solution of sample is injected into a column of porous material (stationary phase) and liquid phase (mobile phase) is pumped at higher pressure through the column. The principle of separation followed is the adsorption of solute on stationary phase based on its affinity towards stationary phase. Ø HPLC is a branch of column chromatography in which the mobile phase is forced through the column at high speed. As a result the analysis time is reduced by 1-2 orders of magnitude relative to classical column chromatography and the use of much smaller particles of the adsorbent or support becomes possible increasing the column efficiency substantially.

Instrumentation:^6,7

(a) Solvent reservoir: The contents of mobile phase are present in glass container. In HPLC the mobile phase or solvent is a mixture of polar and non-polar liquid components. Depending on the composition of sample, the polar and non-polar solvents will be varied.

(b) Pump: A high-pressure pump (solvent delivery system or solvent manager) is used to generate and meter a specified flow rate of mobile phase, typically milli litters per minute. The pump suctions the mobile phase from solvent reservoir and forces it to column and then passes to detector. Typical pumps can reach pressures in the range of 6000-9000 psi. Pump pressure depends on column dimension, particle size, flow rate and composition of mobile phase.

(c) Sample injector: The injector serves to introduce the liquid sample into the flow stream of the mobile phase. Typical sample volumes are 5- to 20- microliters (µL). The injector must also be able to withstand the high pressures of the liquid system. An auto sampler is the automatic version for when the user has many samples to analyse or when manual injections are not Practical.

(d) Column: Considered the “heart of the chromatograph” the column’s stationary phase separates the sample components of interest using various physical and chemical parameters. The pump must push hard to move the mobile phase through the column and this resistance causes a high pressure within the chromatograph. Provides separation through high pressure created by the small particles.

The types of columns are: A guard column is introduced before the analytical column to increase the life of the analytical column by removing not only particulate matter and contaminants from the solvents but also sample components that bind irreversibly to the stationary phase. Analytical columns is the heart of High-performance liquid chromatography. Liquid-chromatographic columns range in length from 10 to 30cm. normally, the columns are straight, with added length, where needed, being gained by coupling two or more columns together. The inside diameter of liquid columns is often 4 to 10mm; the most common particle size of packing is 5 or 10. The most common column currently in use is one that is 25cm in length, 4.6 mm inside diameter, and packed with 5mm particles. Columns of this type contain 40,000 to 60,000 plates/meter.

(e) Detector: The detector can see (detect) the individual molecules that come out (elute) from the column. A detector serves to measure the amount of those molecules so that the chemist can quantitatively analyse the sample components. The detector provides an output to a recorder or computer that results in the liquid chromatogram (i.e., the graph of the detector response).

(f) Data collection devices or Integrated: Signals from the detector might be gathered on graph recorders or electronic integrators that fluctuate in many-sided quality and in their capacity to process, store and reprocess chromatographic information. This chromatogram can be analysed manually or by specialized software used in the procedures that aim to purify a certain compound from a mixture. i.e. the output of this system is data only.

Pharmaceutical applications:⁸

1. Tablet dissolution study of the pharmaceutical dosage form.

2. To control drug stability, Shelf-life determination.

3. Identification of active ingredients.

4. Pharmaceutical quality control.

5. Tablet dissolution of pharmaceutical dosage forms.

Environmental applications ⁹

1. Detection of phenol compounds in drinking water.

2. Identification of diphenhydramine in sedimented samples.

3. Bio-monitoring of pollutant.

4. Rapid separation and identification of carbonyl compounds by HPLC.

5. LC/MS/MS solution for pharmaceuticals and personal care products in water, sediment, soil and biosolids by HPLC/MS/MS.

6. Determination of 3-mercaptopropionic acid by HPLC

Foodand Flavor analysis¹⁰

1. Rapid screening and analysis of components in nonalcoholic drinks.

2. Measurement of quality of soft drugs and water.

3. Sugar analysis in fruit juices.

4. Analysis of polycyclic compounds in vegetables.

5. preservative analysis.

6. Multiresidue analysis of lots of pesticides in food samples by LC triple quadrupole MS.

Clinical applications:^11,12

1. Catecholamines such as epinephrine and dopamine are

highly important for many biological functions. Analyzing their precursors and metabolites can provide diagnosis of diseases such as Parkinson’s disease, heart disease, and muscular dystrophy.

2. Quantification of ions in human urine analysis of antibiotics in blood plasma.

3. Estimation of bilirubin and biliviridin in blood plasma in case of hepatic disorders.

4. Detection of endogenous neuropeptides in extracellularfluids of the brain.

HYPHENATED TECHNIQUES^13,14

Hyphenated techniques for species-selective analysis The various possibilities for the on-line coupling of a separation technique with an element (moiety, species)-specific detector for bioinorganic speciation analysis include different types of HPLC or electrophoresis for separation, and atomic spectrometry (or molecular MS) for detection. The hyphenated techniques available for species-selective analysis in biological materials are schematically shown in Fig. 1. The presence of a metal bound to a bio macromolecule in a sample is considered to be the prerequisite of using an element-specific detector. Nevertheless, some reports have indicated the possibility of employing a coupled technique to the analysis for a metal-free compound, provided that the latter is derivatized on-column or post-column by saturating the metal binding sites with a metal.

New Amendment in High-Performance Liquid Chromatography Technique^15,16,17

Several advancements have been made in the classical HPLC technique and these newer techniques are Rapid Resolution Liquid Chromatography (RRLC), Ultra-Performance Liquid Chromatography (UPLC), Ultra-Fast Liquid Chromatography (UFLC) and Nano Liquid Chromatography (Nano LC). The description of these chromatographic techniques and their comparison with HPLC are summarized in Table 1 and discussed in the following sections

· Rapid Resolution Liquid chromatography (RRLC)

· Ultra Performance Liquid chromatography (UPLC)

· Ultra Fast Liquid chromatography (UFLC)

· Nano Liquid chromatography (Nano LC)

RAPID RESOLUTION LIQUID CHROM ATOGRAPHY RRLC¹⁸

system was designed to provide highest analysis speed, resolution and pressure at a minimum This analysis has become a routine method in the pharmaceutical industry. It holds excellent peak shapes, enhanced reproducibility, high sensitivity, high-speed detection with reduced analysis cost, and is valuable for the quality control of herbal medicines The separation resolution and reduction of analysis time has continually improved in High Performance Liquid Chromatography (HPLC). Since then, HPLC using smaller particles has become more popular For further improvement, column efficiency must be increased. The relationship among separation efficiency, the mobile phase linear velocity and particle size was investigated in detail in the early 1970 s. This and other systematic investigations have led to high throughput and high resolution HPLC that we know today. The shortening in analysis time is due to the use of ashorter column length. However, a shorter column may lead to a loss of theoretical plates, hence a decrease in chromatographic resolution that may be required for a complex mixture of compounds. To offset the potential loss of resolution, the use of smaller size particles has resulted in more efficient columns. Long columns packed with smaller particles result in higher efficiency and higher resolution, with new RRLC technology, analysis time can be significantly reduced without losing chromatographic resolution

ULTRA PERFORM ANCE LIQUID CHROM ATOGRAPHY UPLC^19-22

refers to Ultra Performance Liquid Chromatography. It improves in three areas: chromatographic resolution, speed and sensitivity analysis. It uses fine particles and saves time and reduces solvent consumption UPLC is comes from HPLC. HPLC has been the evolution of the packing materials used to effect the separation. An underlying principle of HPLC indicates that as column packing particle size decreases, efficiency and thus resolution also increases. As particle size decreases to less than 2.5µm, there is a significant gain in efficiency and it’s doesn’t diminish at increased linear velocities or flow rates according to the common Van Demeter equation 16. By using smaller particles, speed and peak capacity (number of peaks resolved per unit time) can be extended to new limits which is known as Ultra Performance.^19-22

ULTRA FAST LIQUID CHROM ATOGRAPHY^23-24

It is ten times higher speed and three times better separation than other LC techniques and offers outstanding speed and separation even at normal pressure levels. By maximizing the column and performance of the entire system UFLC minimizes the deviation from the van Demeter theory The Prominence UFLC series provides ultrafast analysis, while maintaining high analytical precision and reliability

NANO LIQUID CHROM ATOGRAPHY^25-26

Some definitions have been found in the literature based on column diameter and mobile phase flow rates. Some workers defined NLC as chromatographic modality having mobile phase flow rate at nano M L per minute. But, the detection aspect of this chromatography which is very important in analytical science was not taken into consideration until then. Later in 2009, Ali et al gave an exact and scientific definition i.e. a modality of chromatography involving samples in nano liters, mobile phase flow rates in nano milliliter per minute, with detection at nano grams per milliliter

RECENT DEVELOPMENTS AND TRENDS OF HPLC^27-48

Automated development in HPTLC:

High performance thin layer chromatography (HPTLC) is an enhanced form of thin layer chromatography (TLC). A number of enhancements can be made to the basic method of thin layer chromatography to automate the different steps, to increase the resolution achieved and to allow more accurate quantitative measurements. Automation is useful to overcome the uncertainty in droplet size and position when the sample is applied to the TLC plate by hand. Nowadays, HPTLC has become a routine analytical technique due to its advantages of reliability in quantitation of analytes at micro and even in nanogram levels and cost effectiveness. Recently an HPLC and HPTLC method has been reported for simultaneous estimation of levocetirizinedihydrochloride and Montelukast sodium in pharmaceutical dosage forms which are either tedious or expensive methods

Development of RP-HPLC:

A simple and rapid method for the determination of ATP, ADP, AMP, NADP+, NAD+, NADPH, and NADH in human erythrocytes. Analysis is performed by reversephase high-performance liquid chromatography on a 5-μm Supelcosil LC-18 column and uv detection. Reversed phase HPLC (RP-HPLC or RPC) has a non-polar stationary phase and an aqueous, moderately polar mobile phase. A simple, fast and precise reversed phase high performance liquid chromatographic method has been developed for the simultaneous determination of Camylofindihydrochloride and Diclofenac Potassium using Methylparaben as an internal standard. Efficient chromatographic separation was achieved on Inertsil C18 column (250mm x 4.6mm, 5µm) as stationary phase with a mobile phase comprising of 0.05M KH2 PO4 in water: Methanol (35:65,v/v) at a flow rate of 1.5mL min-1, column temperature of 27°C and UV detection at 220 nm. The proposed method was validated for linearity, accuracy, precision, sensitivity, robustness and solution stability. Linearity, accuracy and precision were found to be acceptable over the ranges of 250-750µg mL-1 for both camylofindihydrochloride and diclofenac potassium. The test solution was found to be stable for 48 hours. It can be conveniently adopted for routine quality control analysis. The literature revealed no method was available for simultaneous determination of this drug in such pharmaceutical preparation by HPLC. A new simple, rapid and precise reverse phase high pressure liquid chromatography (RP-HPLC) method was developed for the simultaneous estimation of amoxicillin trihydrate and bromhexine hydrochloride from oily suspension. An ODS C18 (250 X 4.5mm ID), 5µ particle size with mobile phase methanol and glacial acetic acid (50:50 v/v) were use. An improved derivatives RPHPLC method with PDA detection has been developed and validated for the simultaneous estimation of tranexamic acid and mefenamic acid in combined tablet dosage form [37]. A rapid, sensitive and specific RP-HPLC method involving UV detection was developed and validated for determination and quantification of Moxifloxacin HCl in tablet dosage form. The method does require only 10 min as run time for analysis which proves the adoptability of the method for the routine quality control of the drug. Two chromatographic methods have been described for the simultaneous determination of levocetirizinedihydrochloride and Montelukast sodium in tablets. The first method was a high performance thin layer chromatographic (HPTLC) separation followed by densitometric measurements on normal phase silica gel 60 F.

Simultaneous analysis:

In the present paper we report our work on development and validation of TLC densitometric method for simultaneous quantification of Bergenin, (+)-Catechin, Gallicin and Gallic acid, and quantification of ß-Sitosterol using HPTLC. Bioautography is a microbial detection method hyphenated with planar chromatography techniques. It is based mainly on antimicrobial or antifungal properties of analyzed substances. Developed method permitted simultaneous quantification of Bergenin, (+)-Catechin, Gallicin and Gallic acid, and showed good resolution and separation from other constituents of extract and was found to be simple, precise, specific, sensitive and accurate. It can be adopted for routine quality control of herbal material and formulations containing Bergeniaciliata. A simple, fast and precise reversed phase high performance liquid chromatographic method has been developed for the simultaneous determination of Camylofindi hydrochloride and Diclofenac Potassium using Methylparaben as an internal standard.

A rapid and accurate liquid chromatographic method has been developed for the simultaneous determination of gatifloxacin (GFC) and ambroxol hydrochloride (AMB) in a tablet formulation. The method was validated for accuracy, precision and recovery studies. Statistical analysis proved the method was precise, reproducible, selective, specific, and accurate for analysis of GFC and AMB. The wide linearity range, sensitivity, accuracy, short retention time, and simple mobile phase imply the method is suitable for routine quality control of formulation products recovery values for Atorvastatin, Ezetimibe and Fenofibrate ranged from 99.7–101.1%, 99.8–101.3% and 99.7–101.7%, respectively. The relative standard deviation for six replicates is always less than 2%. This HPLC method is successfully applied to the simultaneous quantitative analysis of the drugs. A reverse phase high pressure liquid chromatography (RP-HPLC) method was developed for the simultaneous estimation of amoxicillin trihydrate and bromhexine hydrochloride from oily suspension. Efficient chromatographic separation was achieved on Inertsil C18 column (250mm x 4.6mm, 5µm) as stationary phase with a mobile phase comprising of 0.05 M KH2 PO4 in water: Methanol (35:65,v/v) at a flow rate of 1.5mL min-1, column temperature of 27°C and UV detection at 220 nm. The retention time of Methylparaben, Camylofindihydrochloride and Diclofenac potassium were 3.60min, 4.85min and 13.10min respectively. The liquid chromatographic method has been developed for the simultaneous determination of gatifloxacin (GFC) and ambroxol hydrochloride (AMB) in a tablet formulation. Chromatographic separation of the two drugs was achieved on a Phenomenex column (200mm×4.6mm, 5µm). Simultaneous determination of Atorvastatin, Ezetimibe and Fenofibrate in their ternary mixture of commercial pharmaceutical preparations. This method, reported first time for a ternary mixture, uses a Kromasil C18, 250 × 4.6mm, 5µm analytical column. An HPLC method for the simultaneous quantitative determination of betamethasone and clotrimazole in cream formulation has been developed

Automated injection technique Automation is a critical demand in modern pharmaceutical analysis and quality control, since strict legislation regarding Good Laboratory (GLP) and Manufacturing Practice (GMP) require extensive analyses of huge amounts of samples during all stages of the manufacturing process of a pharmaceutical formulation. An automated flow injection determination of some phenothiazine derivatives, based on their oxidation with iron (III) in a strongly acidic medium. A flow injection spectrophotometric procedure is proposed for determining adrenaline in pharmaceutical formulations. A simple, rapid and precise reversedphase liquid chromatographic method is developed for simultaneous determination of Atorvastatin, Ezetimibe and Fenofibrate in their ternary mixture of commercial pharmaceutical preparations. Extensive analyses of huge amounts of samples during all stages of the Manufacturing process of a pharmaceutical formulation. Automation is a critical demand in modern pharmaceutical analysis and quality control, since strict legislation regarding Good Laboratory (GLP) and Manufacturing Practice (GMP) require extensive analyses of huge amounts of samples during all stages of the manufacturing process of a pharmaceutical formulation. Future trends in automated injections: The auto-injectors are having rapid growth in the fields of Pharmacy. This article discusses the benefits driving this growth, the current state of the technology. An auto-injector may be described as a device which completely or partially replaces the activities involved in parenteral drug delivery from a standard syringe. It is likely that there will be continued growth in next few years in the variety of auto-injectors, with competition to meet requirements spurring innovation in new therapy areas. The deserved success is underpinned by the principles of quality, safety and efficacy and will certainly continue to be an important part of patients’ lives, particularly those who enjoy the benefits of taking an active role in their treatment. Bioequalence and bioavailability studies of pharmacokinetics Bioequivalence approaches are commonly based on the two one-sided tests principle. Average bioequivalence is the special case of population bioequivalence, where the entire distributions of bioavailabilities are considered. Statistical approaches for population bioequivalence are suggested. Population bioequivalence is an improvement over average bioequivalence, because average bioequivalence does not consider the variability of the formulations. Various experiments have been performed to improve the bioavailability of this drug such as binding with polymers.

Challenges and Future Directions^49,52

A. Common challenges in RP HPLC method development:

Despite its widespread use and effectiveness, RP HPLC method development is not without its challenges. Here are some common challenges that researchers and practitioners may encounter:

· Stationary phase selectivity: Selecting the most appropriate stationary phase for a particular sample can be challenging, especially when dealing with complex mixtures. The use of alternative selectivity columns or mixed-mode columns can help address this challenge.

· Optimization of parameters: Optimizing the parameters of an RP HPLC method, such as column temperature, flow rate, and mobile phase composition, can be time-consuming and require significant trial and error. Intelligent software and automation can help expedite this process

· Matrix interference: Sample matrices can interfere with separation and detection, leading to reduced sensitivity and selectivity. Sample preparation techniques, such as solid-phase extraction, can help remove matrix interference.

· Column degradation: Columns can degrade over time due to sample matrix effects, column overload, and other factors. Periodic column maintenance and replacement can help address this challenge. In terms of future directions, the following areas are likely to see continued development and improvement in RP HPLC method development:

· Column technology: As discussed earlier, new column technologies, such as monolithic columns and coreshell particles, are likely to see increased use and development.

· Stationary phase design: Researchers are continuing to explore new stationary phase chemistries and designs to improve selectivity and efficiency.

· Automation and artificial intelligence: The use of automation and artificial intelligence in RP HPLC method development is likely to increase, with the potential for more efficient and effective optimization strategies.

· Miniaturization: Miniaturization of RP HPLC systems, such as microfluidic chips, could lead to improved speed, sensitivity, and portability. Overall, RP HPLC method development will continue to play an important role in modern analytical chemistry, with ongoing improvements and innovations addressing existing challenges and expanding its range of applications

B. Emerging Challenges in RP HPLC Method Development:

There are several emerging challenges in RP HPLC method development that researchers and practitioners need to be aware of:

· Analysis of large biomolecules: RP HPLC is commonly used for the analysis of small molecules, but its application to large biomolecules, such as proteins and peptides, can be challenging due to their size, complexity, and hydrophobicity. New column technologies and sample preparation techniques, such as sizeexclusion chromatography and protein digestion, are being developed to address these challenges.

· Analysis of chiral compounds: Chiral compounds are molecules that exist in two or more mirror-image forms, and their separation is critical in many industries, including pharmaceuticals, agrochemicals, and flavors and fragrances. While RP HPLC can be used for chiral separations, it often requires the use of chiral stationary phases or derivatization techniques, which can be time-consuming and costly

· Analysis of polar compounds: RP HPLC is not well-suited for the analysis of highly polar compounds, such as carbohydrates and organic acids, due to their poor retention on RP columns. Alternative modes, such as hydrophilic interaction chromatography (HILIC), are being developed to address this challenge.

· Analysis of trace impurities: RP HPLC is commonly used for the analysis of impurities in pharmaceuticals and other products, but its sensitivity for trace impurities can be limited. The use of high-resolution mass spectrometry (HRMS) and other advanced detection techniques can improve sensitivity and selectivity for trace impurities

In summary, the emerging challenges in RP HPLC method development reflect the growing demand for more efficient, sensitive, and selective analytical techniques in various industries. Continued innovation and development in RP HPLC, as well as alternative chromatographic modes, will be critical in addressing these challenges and advancing modern analytical chemistry.

Table: Recent advances in RP HPLC method development⁵³

Technique	Description	Advantages
Ultra-high performance liquid chromatography (UHPLC)	Utilizes columns packed with smaller particles (typically < 2μm) and higher pressures (up to 1000 bar) for faster separations and higher resolution	Improved speed, resolution, and sensitivity
Monolithic columns	Consist of a single piece of porous material, providing higher flow rates and faster separations	Improved speed and resolution, reduced backpressure
Stationary phase coatings	Modify the surface of the column to provide improved selectivity and/or reduced non-specific adsorption	Improved selectivity and sensitivity
2D-LC	Combines two complementary separation modes (e.g., size exclusion and RP) to provide higher resolution and selectivity	Improved resolution and selectivity for complex samples

Table: Applications of RP HPLC method development in various industries ⁵⁴

Industry	Applications
Pharmaceutical	Drug development and quality control, impurity analysis, pharmacokinetic studies
Food and beverage	Analysis of additives, contaminants, and nutritional components
Environmental	Analysis of pollutants, toxins, and metabolites in air, water, and soil
Forensic	Analysis of drugs, toxins, and metabolites in biological samples
Biotechnology	Analysis of proteins, peptides, and nucleic acids in research and development

These tables provide a useful summary of the recent advances in RP HPLC method development, as well as the applications of RP HPLC in various industries.

Future Directions for RP HPLC Method Development^5,6

Future directions for RP HPLC method development are centeredaround improving its efficiency, sensitivity, and selectivity, as well as expanding its capabilities for new and emerging applications. Some key areas of focus for future research and development include:

· Development of new stationary phases: Novel stationary phases with improved selectivity, stability, and durability are being developed to enhance the performance of RP HPLC. For example, hybrid stationary phases, such as core-shell and porous organic polymers, are being explored for their unique properties and potential applications.

· Development of new detection techniques: Advanced detection techniques, such as mass spectrometry, fluorescence, and electrochemical detection, are being integrated into RP HPLC systems to improve sensitivity, selectivity, and accuracy. The development of new detection technologies that can detect analytes at low concentrations and in complex matrices will be critical for future applications.

CONCLUSION:

In conclusion, this review has provided a comprehensive overview of the principles, optimization strategies, recent advances, applications, and challenges in RP HPLC method development. The key findings of this review include the importance of optimizing key factors such as stationary phase, mobile phase composition, and column temperature, as well as the potential benefits of using novel technologies such as UHPLC and 2D-LC. Additionally, we highlighted the diverse applications of RP HPLC in various industries, including pharmaceuticals, food and beverage, environmental analysis, forensic science, and biotechnology. The implications of these findings for the field of analytical chemistry are significant. The continued development and optimization of RP HPLC methods will enable more accurate, sensitive, and selective analyses, leading to improved product quality and safety, as well as better protection of the environment. Moreover, the use of RP HPLC in combination with other analytical techniques such as mass spectrometry and NMR spectroscopy will provide even greater insight into complex mixtures. Suggestions for future research in RP HPLC method development include exploring the potential of new stationary phases and column technologies, as well as developing improved sample preparation techniques and optimization strategies. Furthermore, the integration of artificial intelligence and machine learning into RP HPLC method development has the potential to greatly enhance the speed and efficiency of method development. Overall, this review highlights the importance of continued innovation and progress in RP HPLC method development, and emphasizes the need for collaboration between researchers and practitioners in academia and industry to advance the field. By addressing the challenges and exploring the emerging trends in RP HPLC method development, we can unlock its full potential as a powerful analytical tool for modern analytical chemistry

REFERENCE:

1. Ettre L S. M.S. Tswett and The Invention of Chromatography, LC-GC., 2003; 21: 458467.

2. Narayudu Yandamuri. Comparative Study of New Trends in HPLC: A Review

3. MukthiThammana. A review on HPLC. 2016:5:22

4. Klaus Unger. Introduction of High Performance Liquid Chromatography. 6-7

5. Gita Chawla and Krishna Kr. Chaudhary. A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications. International Journal of Pharmaceutical Chemistry and Analysis. 2019; 6(2): 27-39

6. Satheeshkumar; M. Gokul; S. Shalini; M. Ukeshraj and M. Mullaivendan. HPLC method development and validation – A review. International Journal of Advance Research, Ideas and Innovations in Technology. 7(3).

7. Abdu Hussen Ali. High-Performance Liquid Chromatography (HPLC): A review. Ann Adv Chem. 2022; 6: 010- 020.

8. Heewon Lee. Pharmaceutical applications of liquid chromatography coupled with mass spectrometry (LC/MS). Journal of Liquid Chromatography and Related Technologies. 2005; 28: 7-8.

9. Salgado P, Visnevschi-Necrasov T, Kiene R.P, Azevedo I, Rocha A.C.S, Almeida C.M.R, Magalhaes C. Determination of 3-mercaptopropionic acid by HPLC: A sensitive method for environmental applications, Journal of Chromatography B, 2015; 992: 103-108.

10. Ma Bokai, Gou Xin Lei, Zhao Xin Ying. Application of high-performance liquid chromatography in food and drug safety analysis. Journal of Food Safety and Quality. 2016; 7: 4295- 4298.

11. Ian M Bird. High-Performance Liquid Chromatography: Principles and Clinical Applications. Br Med J. 1989; 299: 783-7.

12. Ante M. Krstulovic. Investigation of catecholamine metabolism using high-performance liquid chromatography: Analytical methodology and clinical applications. Journal of Chromatography B: Biomedical Sciences and Applications. 1982;229: 1-34.

13. K. Takatera and T. Watanabe. Anal. Chem. 1993; 65: 3644.

14. J. Szpunar. Trends Anal. Chem., 2000; 19: 127

15. Yandamuri, N.; Nagabattula, K.R.S.; Kurra, S.S.; Batthula, S.; Allada, L.P.S.N.; Bandam. A Review: HPLC method development and validation. Int. J. Anal. Bioanal. Chem. 2015; 5(4): 76-81.

16. Rao, B.V.; Sowjanya, G.N.; Ajitha, A.; Rao, V.U.M. Review on stability indicating HPLC method development. World J. Pharm. Pharm. Sci. 2015; 4(8): 405-423.

17. www.waters.com/ webassets/ cms/ category/ media/ other_i mages/ primer_e_lcsystem.jpg

18. Yoshida T, Ronald E.M and Kumagai H. High−Speed Analyses using Rapid Resolution Liquid Chromatography on ZORBAX column packed 1.8 µm Particles. Chromatography. 2007; 28: 81-87.

19. Dr. M ichael E. Swartz and Brian J. Murphy. Ultra performance liquid chromatography: Tomorrow’s HPLC technology today, Novel Phases for HPLC, as published in LPI- June 2004 URL: www.labint-online.com/ uploads/ tx_ttproducts/ datasheet/ ultra-performance-liquid-chromatographytomorrow's-hplc-technology-today.pdf

20. M eenakshi D, Meenaxi M. A Review on Ultra Performance Liquid Chromatography. International Journal of Drug Development and Research. 2013; 5?: 29-34

21. Ashok Kumar, Gautam S, Anroop N and Rishbha S, UPLC: A Preem inent technique in Pharmaceutical Analysis, Acta Poloniae Pharmaceutica Drug Research. 2012; 69: 371-380.

22. Swartz M. E. and M urphy B., Pharm. Formulation Quality. 2004; 6: 40.

23. Ultra-fast liquid chromatography, URL:.http/ / Schimadzu.co.UK.

24. www.shimadzu.com/ about/ pressrelease/ oh80jt000000 abel.html

25. He Qing., Integrated nano liquid chromatography system on a chip., Ph.D.Thesis, California Institute of Technology, Pasadena, California, USA, June 21, 2005.

26. http:/ www.justchromatography.com/ nano-hplc/ nano-lcdefinition

27. Shuijun L, Gangyi L, Jingying J, Xiaochuan L, Chen Y (2006) J Pharm Biomed Anal 40: 987-992

28. Vishwanathan K, Bartlett MG, Steward JT. Determination of gatifloxian in human plasma by liquid chromatography/ electrospray tandem mass spectroscopy. Rapid Commun Mass Spectrom. 2001; 15: 915-919.

29. Song HH, Choi KS, Kim CW, Kwon YE. Pharmacokinetic Profiles of Two Branded Formulations of Piroxicam 20mg in Healthy Korean Volunteers by a Rapid Isocratic HPLC Method. J BioequivAvailab. 2009; 1: 074-081.

30. Ni Y, Liu Y, Kokot S. Two-dimensional fingerprinting approach for comparison of complex substances analysed by HPLC-UV and fluorescence detection. Analyst. 2011; 136:550-559

31. Elbarbry FA, Mabrouk MM, El-Dway MA. Determination of the analgesic components of Spasmomigraine tablet by liquid chromatography with ultraviolet detection. J AOAC Int. 2007; 90: 94-101a

32. Hinz B, Chevts J, Renner B, Wuttke H, Rau T, et al. Bioavailability of diclofenac potassium at low doses. Br J Clin Pharmacol. 2007; 59: 80-84

33. G Subramanian, P Musmade, S Agarwal, N Udupa. Simultaneous RP HPLC estimation of tinidazole, diclofenac potassium and paracetamol in tablets. Indian Journal of Pharmaceutical Sciences. 2004; 66: 694-696a.

34. Barde PS, Desai AY, Roy MNS, Vaidya VV. Simultaneous RP HPLC determination of Camylofindihydrochloride in Pharmaceutical preparation. TSI Journal. 2008; 7(10)a.

35. Singh RR, Rathnam MV, Vegesna R (2008) Simultaneous RP HPLC determination of Camylofindihydrochloride and Paracetamol in Pharmaceutical preparations.TSI Journal 7(11).

36. Sethi PD.Identification of Drugs in Pharmaceutical Formulations by Thin Layer Chromatography. CBS Publishers, New Delhi. 1992

37. Ashok kumar S, Senthil Raja M, Perumal P. RP-HPLC Method Development and Validation for Simultaneous Estimation of Montelukast Sodium and levocetirizineDihydrochloride. International Journal of Pharmaceutical Research. 2009; 1: 8-12.

38. Smita Sharma MC, Sharma DV, Kohlib AD, Sharma C. Development and validation of tlc-densitometry method for simultaneous quantification of montelukast sodium and levocetirizinedihydrochloride pharmaceutical solid dosage form. Der Pharmacia Lettre. 2010; 2: 489-494.

39. Rathnam MV, Singh RR. Simultaneous RP HPLC Determination of CamylofinDihydrochloride and Diclofenac Potassium in Pharmaceutical Preparations. Pharm Anal Acta. 2010; 1:108.

40. Natesan S, Thanasekaran D, Krishnaswami V, Ponnusamy C. Improved RP- HPLC Method for the Simultaneous Estimation of Tranexamic Acid and Mefenamic Acid in Tablet Dosage Form. Pharm Anal Acta. 2011; 2:115.

41. Subbaiah PR, Kumudhavalli MV, Saravanan C, Kumar M, Chandira RM. Method Development and Validation for estimation of MoxifloxacinHCl in tablet dosage form by RP-HPLC method. Pharm Anal Acta. 2010; 1:109.

42. Dharmender R, Madhavi T, Reena A, Sheetal A. Simultaneous Quantification of Bergenin, (+)-Catechin, Gallicin and Gallic acid; and quantification of β-Sitosterol using HPTLC from Bergeniaciliata (Haw.) Sternb. Forma ligulata Yeo (Pasanbhe da). Pharm Anal Acta. 2010; 1: 104.

43. Sonawane LV, Bari SB. Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Amoxicillin Trihydrate and Bromhexine Hydrochloride from Oily Suspension. Pharm Anal Acta. 2010; 1:107.

44. Prabu SL, Srinivasan M, Thiagarajan S, Marina Q. Simultaneous Determination of Gatifloxacin and Ambroxol Hydrochloride in a Tablet Formulation by Liquid Chromatography. Pharm Anal Acta. 2010; 1:110.

45. Lacassie E, Gaulier JM, Marquet P, Rabatel JF, Lachâtre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. Journal of Chromatography B. 2000; 742: 229-238a

46. Sharma A, Conway WD, Staudinger RM. Reverse-phase highperformance liquid chromatographic determination of taxol in mouse plasma. J Chromatogr. 1994; 655: 315-319.

47. Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Frolov VM, et al. Phase 2 Trial V-5 Immunitor (V5) in Patients with Chronic Hepatitis- C Co-infected with HIV and Mycobacterium tuberculosis. J Vaccines Vaccin. 2010; 1: 103.

48. Nannan Panday VR, MeerumTerwot JM, Ten BokkelHuinink WW. The role of pro drug therapy in the treatment of cancer. Proc Am SocClinOncol. 2010; 17: 742a

49. Rezaei, Z., andAsadollahi-Baboli, M. RP-HPLC method development and validation for the determination of four major bioactive flavonoids in onion (Allium cepa) extract. Analytical Chemistry Letters. 2021; 11(1): 78-92.

50. S. Saha, S. Bera, P. Banerjee, S. Bose, and A. B. Chatterjee, Recent advances in the development and application of monolithic stationary phases for reversed-phase liquid chromatography. TrAC Trends Anal. Chem. 2020; 123: 115769, 2020.

51. M. I. Alam, N. N. Chowdhury, and M. Z. Rahman. Recent advances in the development of reversed-phase high-performance liquid chromatography methods for the analysis of small molecules. J. Chromatogr. A. 2020; 1626: 461298.

52. K. Ma, Y. Xiong, Y. Liang, and X. Qiao. Recent advances in the development of chiral stationary phases for reversed-phase liquid chromatography. J. Sep. Sci. 2021; 44(1); 55-72.

53. B. W. Armstrong. Recent advances in chiral stationary phases for reversed-phase high-performance liquid chromatography. J. Chromatogr. A. 2017; 1511: 113-125.

54. J. Wang, Y. Luo, J. Hu, J. Cheng, and H. Chen. Recent advances in the application of deep eutectic solvents in reversed-phase liquid chromatography. J. Chromatogr. A. 2021; 1643: 462028.

Received on 05.02.2024 Modified on 06.03.2024

Asian J. Pharm. Ana. 2024; 14(2):95-103.

DOI: 10.52711/2231-5675.2024.00017

¹Department of Quality Assurance,

Kisan Vidya Prasarak Sanstha's, Institute of Pharmaceutical Education, Boradi 425405.

1Department of Quality Assurance,

Kisan Vidya Prasarak Sanstha's, Institute of Pharmaceutical Education, Boradi 425405.

¹Department of Quality Assurance,